Status:

NOT_YET_RECRUITING

A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC

Lead Sponsor:

Biotheus Inc.

Conditions:

HCC

Liver Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This study to evaluate the preliminary efficacy, safety and pharmacokinetics of PM8002 combined with PM1009 in Patients with first-line Hepatocellular Carcinoma.

Detailed Description

The study is divided into two parts. The first part is a phase Ib, single-arm study, which is planned to enroll 3-28 subjects. The second part is a phase II randomized, parallel-controlled, four-arm,...

Eligibility Criteria

Inclusion

  • Voluntary participation in clinical studies;
  • Male or female, aged ≥ 18 years;
  • Pathologically or clinically confirmed (according to AASLD), unresectable locally advanced and/or metastatic HCC;
  • Child-Pugh liver function score ≤7;
  • No prior systemic therapy for locally advanced or metastatic and/or unresectable HCC;
  • At least 1 measurable lesion ;
  • Adequate organ function;
  • ECOG score of 0 to 1;
  • Life expectancy ≥ 12 weeks;

Exclusion

  • Pathologically confirmed fibrolamellar HCC, sarcomatoid HCC, cholangiocarcinoma and other components;
  • History of serious allergic diseases;
  • The toxicity of previous anti-tumor therapy has not been alleviated;
  • History of severe cardiovascular diseases within 6 months;
  • Current presence of uncontrolled pleural, pericardial, and peritoneal effusions;
  • History of allogeneic hematopoietic stem cell transplantation or allogeneic organ transplantation;
  • History of alcohol abuse, psychotropic substance abuse or drug abuse;
  • Human immunodeficiency virus (HIV) infection or known acquired immunodeficiency syndrome;
  • Pregnant or lactating women;
  • Other conditions considered unsuitable for this study by the investigator.

Key Trial Info

Start Date :

December 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT06584071

Start Date

December 1 2024

End Date

December 1 2027

Last Update

December 16 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.